HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
T J Littlewood Selected Research
T J Littlewood Research Topics
Disease
8
Neoplasms (Cancer)
08/2014 - 01/2001
3
Anemia
06/2001 - 01/2001
2
Iron Deficiencies
08/2014 - 06/2008
2
Fatigue
12/2002 - 06/2001
2
Hematologic Neoplasms (Hematological Malignancy)
06/2001 - 03/2001
1
Infections
05/2009
1
Renal Insufficiency (Renal Failure)
06/2008
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2004
1
Sleep Initiation and Maintenance Disorders (Insomnia)
04/2004
1
Disease Progression
12/2002
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2002
1
Bone Diseases (Bone Disease)
05/2002
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2002
1
Necrosis
05/2002
1
Pemphigus (Pemphigus Vulgaris)
06/2001
1
Chronic Disease (Chronic Diseases)
03/2001
1
Refractory Anemia with Excess of Blasts (RAEM)
01/2001
1
Colorectal Neoplasms (Colorectal Cancer)
06/2000
1
Hypoxia (Hypoxemia)
06/2000
Drug/Important Bio-Agent (IBA)
3
Hemoglobins (Hemoglobin)
IBA
06/2001 - 01/2001
2
fludarabine phosphate (Fludara)
FDA Link
Generic
04/2004 - 01/2001
2
Platinum
IBA
12/2002 - 01/2002
2
Epoetin Alfa (Epogen)
FDA Link
12/2002 - 06/2001
2
Cytokines
IBA
05/2002 - 03/2001
1
Alemtuzumab (Campath)
FDA Link
05/2009
1
Hematinics
IBA
06/2008
1
Iron
IBA
06/2008
1
Tablets
IBA
04/2004
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
08/2002
1
Interleukin-1 (Interleukin 1)
IBA
05/2002
1
Interleukin-6 (Interleukin 6)
IBA
05/2002
1
Nucleosides
IBA
06/2001
1
fludarabine
IBA
06/2001
1
Erythropoietin
FDA Link
03/2001
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2001
1
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2001
1
5-(2-formyl-3-hydroxyphenoxy)pentanoic acid
IBA
06/2000
1
Fluorouracil (Carac)
FDA Link
Generic
06/2000
1
Oxygen (Dioxygen)
IBA
06/2000
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
06/2000
1
Acids
IBA
06/2000
Therapy/Procedure
5
Drug Therapy (Chemotherapy)
08/2014 - 01/2001
1
Aftercare (After-Treatment)
04/2004
1
Therapeutics
12/2002